InvestorsHub Logo
Followers 2
Posts 384
Boards Moderated 0
Alias Born 02/13/2017

Re: None

Thursday, 06/22/2017 9:51:09 AM

Thursday, June 22, 2017 9:51:09 AM

Post# of 34575
New @market financing removes any uncertainty regarding funding for next two years. TPIV can focus on clinical execution, PolyStart, additional collaborations and other value adds. Could finally attract funds/institutional investors, now they can more effectively model value including assessing upside. Now it is time for Glynn to deliver.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News